Literature DB >> 15353085

Human blastocysts for the development of embryonic stem cells.

Anita Sjögren1, Thorir Hardarson, Katarina Andersson, Gunilla Caisander, Monalill Lundquist, Matts Wikland, Henrik Semb, Lars Hamberger.   

Abstract

Establishment of human embryonic stem cells (hES) from surplus human IVF embryos has been successful when both fresh and frozen-thawed cleavage stage embryos have been cultured to the blastocyst stage. This study reports the characteristics of the starting material, the blastocysts, for hES cell lines that were first derived at the University of Gothenburg, Sahlgrenska University Hospital in 1999. Twenty-two hES cell lines were derived by Cellartis AB from 114 blastocysts, giving an overall success rate of 19.3%. The blastocysts from which the hES cell lines were established were of varying morphological quality, both fresh and frozen-thawed. Two techniques of hES establishment were applied, i.e. direct application of the blastocysts on feeder cells or the standard immunosurgery method. It was further found that the efficiency by which frozen-thawed embryos gave rise to new hES cell lines was 3.7 times better than with fresh surplus embryos. These findings suggest that frozen-thawed embryos are superior to fresh surplus human embryos in hES cell establishment, which also avoids specific ethical problems associated with embryo donation in a fresh IVF cycle.

Entities:  

Mesh:

Year:  2004        PMID: 15353085     DOI: 10.1016/s1472-6483(10)62149-9

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

1.  The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking.

Authors:  Mikael C O Englund; Gunilla Caisander; Karin Noaksson; Katarina Emanuelsson; Kersti Lundin; Christina Bergh; Charles Hansson; Henrik Semb; Raimund Strehl; Johan Hyllner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

Review 2.  Stem Cells in Cardiovascular Medicine: the Road to Regenerative Therapies.

Authors:  Christopher W Anderson; Nicole Boardman; Jiesi Luo; Jinkyu Park; Yibing Qyang
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 3.  Stem cells in clinical practice: applications and warnings.

Authors:  Daniele Lodi; Tommaso Iannitti; Beniamino Palmieri
Journal:  J Exp Clin Cancer Res       Date:  2011-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.